Jenner, P, A Mori, RA Hauser, M Morelli, BB Fredholm, and JF Chen. 2009. “Adenosine, Adenosine A2A Antagonists, and Parkinson’s Disease.”. Parkinsonism Relat Disord.
Publications
2009
Cobb, SA, C Wider, OA Ross, IF Mata, CH Adler, A Rajput, AH Rajput, et al. 2009. “GCH1 in Early-Onset Parkinson’s Disease.”. Mov Disord.
Olanow, CW, O Rascol, RA Hauser, PD Feigin, J Jankovic, A Lang, W Langston, et al. 2009. “ADAGIO Study Investigators. A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease.”. N Engl J Med.
Hauser, RA, J Bronzova, C Sampaio, AE Lang, O Rascol, A Theeuwes, and SV Van De Witte. 2009. “Safety and Tolerability of Pardoprunox, a New Partial Dopamine Agonist, in a Randomized, Controlled Study of Patients With Advanced Parkinson’s Disease”. Eur Neurol.
Hauser, RA, P Auinger, and D Oakes. 2009. “Levodopa Response in Early Parkinson’s Disease”. Mov Disord.
Jahan, I, RA Hauser, KL Sullivan, A Miller, and TA Zesiewicz. 2009. “Sleep Disorders in Parkinson’s Disease.”. Neuropsychiatr Dis Treat.
Sethi, KD, RA Hauser, SH Isaacson, and T McClain. 2009. “Levodopa/Carbidopa/Entacapone 200/50/200 Mg (Stalevo 200) in the Treatment of Parkinson’s Disease: A Case Series”. J Cases.
Tanner, CM, GW Ross, SA Jewell, RA Hauser, J Jankovic, SA Factor, S Bressman, et al. 2009. “Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study”. Arch Neurol.
Cicchetti, F, S Saporta, RA Hauser, M Parent, M Saint-Pierre, PR Sandberg, XJ Li, et al. 2009. “Neural Transplants in Patients With Huntington’s Disease Undergo Disease-Like Neuronal Degeneration.”. Proc Natl Acad Sci USA.
Seeberger, LC, and RA Hauser. 2009. “Levodopa/Carbidopa/Entacapone in Parkinson’s Disease. Expert Rev Neurother”. Expert Rev Neurother.